NACDS and NCPA defend TRICARE beneficiaries' right to choose community pharmacy
February 28th 2011NACDS and NCPA authored a joint letter to Senate Armed Services Committee Chairman Carl Levin (D-Mich.), emphasizing the ability of community pharmacies to help lower prescription drug costs, and the importance of maintaining the right of military families and veterans to choose where they fill their prescriptions through the TRICARE program.
Merck Serono pulls European application for oral MS drug Movectro
February 23rd 2011Merck Serono Europe informed the European Medicines Agency that it was withdrawing its marketing authorization application for oral cladribine (Movectro), 10-mg tablets, intended for the treatment of relapsing-remitting multiple sclerosis.
Forest to acquire Clinical Data
February 23rd 2011Forest Laboratories $1.2 billion acquisition of Clinical Data, the developer of Viibryd (vilazodone HCl) for the treatment of adults with major depressive disorder, is expected to allow Forest to leverage its existing presence in the antidepressant category.
Independent pharmacies must unify to fight PBM industry
February 22nd 2011The independent pharmacy industry needs to unite and develop an internal public relations campaign to mobilize pharmacy store owners and patients to fight for their prescription rights. This was one of the suggestions made during a PBM Discussion Panel for Independent Pharmacy.